Skip to main content
SpringerLink
Log in

The effect of calphostin C, a potent photodependent protein kinase C inhibitor, on the proliferation of glioma cells in vitro

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Recent studies have suggested that the proliferation of malignant gliomas may result from activation of protein kinase C (PKC)-mediated pathways; conversely, inhibitionof PKC may provide a strategy for blocking tumor growth.In the current studies, we examined the effect of a novelPKC inhibitor, calphostin C, which is a selective, highlypotent, photo-activatable inhibitor of the PKC regulatorydomain, on the proliferation and viability of three established and three low-passage malignant glioma cell lines, four low-passage low-grade glioma cell lines, and in adult human and neonatal rat non-neoplastic astrocyte cell lines in vitro. Under light-treated conditions, calphostin C consistently inhibited cell proliferation in each of the tumor cell lines and in the neonatal rat astrocyte cell line with a 50% effective concentration of 30 to 50 ng/ml (40 to 60 nm), which was comparable to the previously reported median inhibitory concentration (IC50) for PKC inhibition by calphostin C. Complete elimination of proliferation was achieved atconcentrations of 50 to 100 ng/ml (60 to 125 nM). Cell viability decreased sharply with calphostin C concentrations of 100 to 300 ng/ml (125 to 380 nM). In contrast, under light-shielded conditions, calphostin C had a comparatively modest effect on cell proliferation and viability, with a median effective concentration of approximately 300 ng/ml. No significant inhibition of proliferationwas noted in the non-neoplastic adult astrocyte cell line under either light-treated or light-shielded conditions. These findings provide further evidence that PKC may play an essential role in mediating the proliferation of both benign and malignant glioma cells in vitro and may also contribute to the proliferation of non-neoplastic immature astrocytes. Light-sensitive inhibition of proliferation and viability by agents such as calphostin C may provide a novel strategy for applying photodynamic therapy to the treatment of neoplastic glial cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT Jr: Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways. J Neurosurg 73: 98–105, 1990

    Google Scholar 

  2. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT Jr: Response of low-passage human malignant gliomas in vitroto stimulation and selective inhibition of growth factor-mediated pathways. J Neurosurg 75: 284–293, 1991

    Google Scholar 

  3. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT Jr: Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro.Cancer Res 50: 7134–7138, 1990

    Google Scholar 

  4. Baltuch GH, Couldwell WT, Villemure J-G, Yong VW: Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen. Neurosurgery 33: 495–501, 1993

    Google Scholar 

  5. Benzil DL, Finkelstein SD, Epstein MH, Finch PW: Expression pattern of ?-protein kinase C in human astrocytomas indicates a role in malignant progression. Cancer Res 52: 2951–2956, 1992

    Google Scholar 

  6. Couldwell WT, Antel JP, Yong VW: Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C. Neurosurgery 31: 717–724, 1992

    Google Scholar 

  7. Couldwell WT, Uhm JH, Antel JP, Yong VW: Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro.Neurosurg 29: 880–887, 1991

    Google Scholar 

  8. Reifenberger G, Deckert M, Wechsler W: Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumors. Acta Neuropathol 78: 166–175, 1989

    Google Scholar 

  9. Todo T, Shitara N, Nakamura H, Takakura K, Ikeda K: Immunohistochemical demonstration of protein kinase C isozymes in human brain tumors. Neurosurg 29: 399–404, 1991

    Google Scholar 

  10. Andrejauskas-Buchdunger E, Regenass U. Differential inhibition of the epidermal growth factor-, platelet-derived growth factor-, and protein kinase C-mediated signal transduction pathways by the staurosporine derivative CGP 41251. Cancer Res 52:5353–5358, 1992.

    Google Scholar 

  11. Meyer T, Regenass U, Fabbro D, Alteri E, Rosel J, Muller M, Caravatti G, Matter A: A derivative of staurosporine (CGP 41251) shows selectivity for protein kinase C inhibition and in vitroanti-proliferative as well as in vivoantitumor activity. Int J Cancer 43: 851–856, 1989

    Google Scholar 

  12. Nakano H, Kobayashi E, Takahashi I, Tamaoki T, Kuzun Y, Iba H: Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60. J Antibiot (Tokyo) 40: 706–708, 1987

    Google Scholar 

  13. Trump DL, Smith DC, Ellis PG, Rogers PM, Schold SC, Winer EP, Panella TJ, Jordan VC, Fine RL: High dose oral tamoxifen, a potential multidrug-resistance-reversal agent: Phase I trial in combination with vinblastine. JNCI 84: 1811–1816, 1992

    Google Scholar 

  14. Bruns RF, Miller FD, Merriman RL, Howbert JJ, Heath WF, Kobayashi E, Takahashi I, Tamaoki T, Nakano H: Inhibition of protein kinase C by calphostin C is light-dependent. Biochem Biophys Res Commun 176: 288–293, 1991

    Google Scholar 

  15. Gopalakrishna R, Chen ZH, Gundimeda U: Irreversible oxidative inactivation of protein kinase C by photosensitive inhibitor calphostin C. FEBS Lett 314: 149–154, 1992

    Google Scholar 

  16. Kobayashi E, Nakano H, Morimoto M, Tamaoki T: Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 159: 548–553, 1989

    Google Scholar 

  17. Riss TL and Moravec RA: Comparison of MTT, XTT, and a novel tetrazolium compound MTS for in vitroproliferation and chemosensitivity assays. Mol Biol Cell 3 (Suppl): 184a, 1992

    Google Scholar 

  18. Aaronson SA: Growth factors and cancer. Science 254: 1146–1153, 1991

    Google Scholar 

  19. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT Jr: Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium. J Neurosurg 73: 106–112, 1990

    Google Scholar 

  20. Filmus J, Pollak M, Cairncross JG, Buick RN: Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell line. Biochem Biophys Res Comm 131: 207–215, 1985

    Google Scholar 

  21. Werner MH, Humphrey PA, Bigner DD, Bigner SH: Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines. Acta Neuropathol 77: 196–201, 1988

    Google Scholar 

  22. Westphal M, Brunken M, Rohde E, Herrmann H-D: Growth factors in cultured human glioma cells: differential effects of FGF, EGF, and PDGF. Canc Lett 38: 283–296, 1988

    Google Scholar 

  23. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature 313: 144–147, 1985

    Google Scholar 

  24. Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN: Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86: 131–140, 1990

    Google Scholar 

  25. Nistér M, Claesson-Welch L, Eriksson A, Heldin C-H, Westermark B: Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines. J Biol Chem 266: 16755–16763, 1991

    Google Scholar 

  26. Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP: Genes for epidermal growth factor receptor, transforming growth factor ?, and epidermal growth factor and their expression in human gliomas in vivo.Cancer Res 51: 2164–2172, 1991

    Google Scholar 

  27. Glick RP, Unterman TG, and Hollis R: Radioimmunoassay of insulin-like growth factors in cyst fluid of central nervous system tumors. J Neurosurg 74: 972–978, 1991

    Google Scholar 

  28. Gross JL, Morrison RS, Eidsvoog K, Herblin WF, Kornblith PL, Dexter DL: Basic fibroblast growth factor: a potential autocrine regulator of human glioma cell growth. J Neurosci Res 27: 289–296, 1990

    Google Scholar 

  29. Fields AP, Tyler G, Kraft AS, May WS: Role of nuclear protein kinase C in the mitogenic response to platelet-derived growth factor. J Cell Science 96: 107–114, 1990

    Google Scholar 

  30. Meisenhelder J, Suh P-G, Rhee SG, Hunter T: Phospholipase C-??is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivoand in vitro .Cell 57: 1109–1122, 1989

    Google Scholar 

  31. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607–614, 1992

    Google Scholar 

  32. Nishizuka Y: Studies and perspectives of the protein kinase C family for cellular regulation. Cancer 63: 1892–1903, 1989

    Google Scholar 

  33. Dong L, Stevens JL, Fabbro D, Jaken S: Regulation of protein kinase C isozymes in kidney regeneration. Cancer Res 53: 4542–4549, 1993

    Google Scholar 

  34. Makowski M, Ballester R, Cayre Y, Rosen OM: Immunochemical evidence that three protein kinase C isoenzymes increase in abundance during HL-60 differentiation induced by dimethyl sulfoxide and retinoic acid. J Biol Chem 263: 3402–3410, 1988

    Google Scholar 

  35. Wada H, Ohno S, Kubo K, Taya C, Tsuji S, Tonehara S, Suzuki K: Cell type-specific expression of the genes for the protein kinase C family: down regulation of mRNAs for PKC? and PKC??upon in vitrodifferentiation of a mouse neuroblastoma cell line neuro 2a. Biochem Biophys Res Commun 165: 533–538, 1989

    Google Scholar 

  36. Hashimoto T, Ase K, Sawamura S, Kikkawa U, Saito N, Tanaka C, Nishizuka Y: Postnatal development of brain-specific subspecies of protein kinase C in rat. J Neurosci 8: 1678–1683, 1988

    Google Scholar 

  37. Neary JT, Norenberg OB, Norenberg MD: Protein kinase C in primary astrocyte cultures: cytoplasmic localization and translocation by a phorbol ester. J Neurochem 50: 1179–1184, 1988

    Google Scholar 

  38. Blumberg PM: Protein kinase C as the receptor for the phorbol ester tumor promoters. Cancer Res 48: 1–8, 1988

    Google Scholar 

  39. Colburn NH, Former BF, Nelson KA, Yuspa SH: Tumor promoter induces anchorage independence irreversibly. Nature 281: 589–591, 1979

    Google Scholar 

  40. Drieger PE, Blumberg PM: The effect of phorbol esters on chicken embryo fibroblasts. Cancer Res 37: 3257–3265, 1977

    Google Scholar 

  41. Housey GM, Johnson MD, Hsiao WLW, O'Brian CA, Murphy JP, Kishmeier P, Weinstein IB: Overproduction of protein kinase C causes disordered growth in rat fibroblasts. Cell 52: 343–354, 1988

    Google Scholar 

  42. Persons DA, Wilkison WO, Bell RM, Finne OJ: Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-1 cDNA. Cell 52: 447–458, 1988

    Google Scholar 

  43. Baltuch GH, Shenouda G, Langleben A, Villemure J-G: High dose tamoxifen in the treatment of recurrent high grade glioma. A report of clinical stabilization and tumour regression. Can J Neurol Sci 20: 168–170, 1993

    Google Scholar 

  44. Couldwell WT, Weiss MH, DeGiorgio CM, Weiner LP, Hinton DR, Ehresmann GR, Conti PS, Apuzzo MLJ: Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery 32: 485–490, 1993

    Google Scholar 

  45. Preul MC, Villemure J-G, Langleben A, Bahary J-P, Shenouda G, LeBlanc R, Pokrupa R, Olivier A, Arnold D: Biochemical effects of high-dose tamoxifen for recurrent malignant glioma monitored in vivowith 1H-MR spectroscopic imaging. J Neurosurg 80: 413A, 1994

    Google Scholar 

  46. Vertosick FT Jr, Selker RG, Arena V: A dose-escalation study of tamoxifen therapy in patients with recurrent glioblastoma multiforme. J Neurosurg 80: 385A, 1994 (abstract)

    Google Scholar 

  47. Vertosick FT Jr, Selker RG, Pollack IF, Arena V: The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: Preliminary results in a series of “failed” patients. Neurosurgery 30: 897–903, 1992

    Google Scholar 

  48. Takahashi I, Nakanishi S, Kobayashi E, Nakano H, Suzuki K, Tamaoki T. Hypericin and pseudohypericin specifically inhibit: protein kinase C: Possible relation to their antiretroviral activity. J Antibiotics 42: 153–157, 1989

    Google Scholar 

  49. Couldwell WT, Gopalkrishna R, Hinton DR, He S, Weiss MH, Law RE, Apuzzo MLJ: Hypericin: a potential antiglioma therapy. Neurosurgery 35: 705–710, 1994

    Google Scholar 

  50. Yong VW, Kim SU, Pleasure DE: Growth factors for fetal and adult human astrocytes in culture. Brain Res 444: 59–66, 1988

    Google Scholar 

  51. Wang S-H, Mathes C, Thompson SH: Membrane toxicity of the protein kinase C inhibitor calphostin A by a free-radical mechanism. Neuroscience Lett 157: 25–28, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Children‘s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    Ian F. Pollack & Stephanie Kawecki

Authors
  1. Ian F. Pollack
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephanie Kawecki
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pollack, I.F., Kawecki, S. The effect of calphostin C, a potent photodependent protein kinase C inhibitor, on the proliferation of glioma cells in vitro. J Neurooncol 31, 255–266 (1997). https://doi.org/10.1023/A:1005729626354

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005729626354

Search

Navigation